Adverse events275

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

1 to 20 of 275

Type	Event	Organ system	Group	Affected	At risk	Events
other	Hypoglycaemia	Metabolism and nutrition disorders	Ertugliflozin 5 mg	12	250	25
other	Hypoglycaemia	Metabolism and nutrition disorders	Ertugliflozin 15 mg	13	248	29
other	Hypoglycaemia	Metabolism and nutrition disorders	Sitagliptin 100 mg	11	247	22
other	Hypoglycaemia	Metabolism and nutrition disorders	Ertugliflozin 5 mg + Sitagliptin 100 mg	9	243	17
other	Hypoglycaemia	Metabolism and nutrition disorders	Ertugliflozin 15 mg + Sitagliptin 100 mg	20	244	42
other	Nasopharyngitis	Infections and infestations	Ertugliflozin 5 mg	6	250	6
other	Nasopharyngitis	Infections and infestations	Ertugliflozin 15 mg	13	248	14
other	Nasopharyngitis	Infections and infestations	Sitagliptin 100 mg	6	247	7
other	Nasopharyngitis	Infections and infestations	Ertugliflozin 5 mg + Sitagliptin 100 mg	12	243	14
other	Nasopharyngitis	Infections and infestations	Ertugliflozin 15 mg + Sitagliptin 100 mg	12	244	13
other	Urinary tract infection	Infections and infestations	Ertugliflozin 5 mg	20	250	24
other	Urinary tract infection	Infections and infestations	Ertugliflozin 15 mg	19	248	23
other	Urinary tract infection	Infections and infestations	Sitagliptin 100 mg	13	247	13
other	Urinary tract infection	Infections and infestations	Ertugliflozin 5 mg + Sitagliptin 100 mg	14	243	18
other	Urinary tract infection	Infections and infestations	Ertugliflozin 15 mg + Sitagliptin 100 mg	8	244	12
serious	Blood potassium decreased	Investigations	Ertugliflozin 5 mg	0	250	0
serious	Blood potassium decreased	Investigations	Ertugliflozin 15 mg	0	248	0
serious	Blood potassium decreased	Investigations	Sitagliptin 100 mg	0	247	0
serious	Blood potassium decreased	Investigations	Ertugliflozin 5 mg + Sitagliptin 100 mg	1	243	1
serious	Blood potassium decreased	Investigations	Ertugliflozin 15 mg + Sitagliptin 100 mg	0	244	0

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02099110/events

API reference For AI assistants

Adverse events275

Sources 3

Read this list from software.